Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Harefuah|January 21, 2021
[UPDATED ISRAELI GUIDELINES FOR THE TREATMENT OF DYSLIPIDEMIA 2020]Hofit Cohen, Ronen Durst, Ophir Avizohar, et al.
Journal of the Neurological Sciences|November 8, 2017
The professional practice and training of neurology in the Asian and Oceanian Region: A cross-sectional survey by the Asian and Oceanian Association of Neurology (AOAN)Artemio Roxas, Man Mohan Mehndiratta, Natan Bornstein, et al.
Acta Clinica Croatica|January 30, 2009
Recommendations for neuropathic pain treatmentVida Demarin, Vanja Basić-Kes, Iris Zavoreo, et al.
Stroke|February 24, 2009
Effectiveness and safety of transcranial laser therapy for acute ischemic strokeJustin A Zivin, Gregory W Albers, Natan Bornstein, et al.
Stroke|August 13, 2019
Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid AtherosclerosisGeorge Ntaios, Balakumar Swaminathan, Scott D Berkowitz, et al.
The New England Journal of Medicine|August 30, 2008
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent strokeRalph L Sacco, Hans-Christoph Diener, Salim Yusuf, et al.
The Lancet. Neurology|September 2, 2008
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled studyHans-Christoph Diener, Ralph L Sacco, Salim Yusuf, et al.
The New England Journal of Medicine|August 30, 2008
Telmisartan to prevent recurrent stroke and cardiovascular eventsSalim Yusuf, Hans-Christoph Diener, Ralph L Sacco, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 12, 2018
Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized TrialScott E Kasner, Pablo Lavados, Mukul Sharma, et al.
European Stroke Journal|April 23, 2019
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trialRobert G Hart, Mukul Sharma, Hardi Mundl, et al.
Pageof 4